Neuberger Berman Group’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Neuberger Berman Group's SMMT Position: Q3 2026 in Review
Neuberger Berman Group opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 541,155 shares worth $9.15M. The stake represents 0.01% of the portfolio and ranks #897 among its holdings.
294 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Neuberger Berman Group held 541,155 shares of Summit Therapeutics worth $9.15M as of Q3 2026.
- Summit Therapeutics was a new Neuberger Berman Group position in Q3 2026.
- Summit Therapeutics made up 0.01% of Neuberger Berman Group's portfolio in Q3 2026, its #897 holding.
- 294 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Neuberger Berman Group's 13F filing for Q3 2026, filed 13 Nov 2026.